Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by jag009  – NJ, 2020-02-04 19:43 (438 d 16:09 ago) – Posting: # 21145
Views: 1,433

» We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.
»
» Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Not sure if this answers your question(I think so but..):
Why not? For both safety and bioanalytical reasons.

J

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 11 (0 registered, 11 guests [including 2 identified bots]).
Forum time: Sunday 12:52 CEST (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5